Doctors are looking for better ways to predict how patients with acute myeloid leukemia will respond to treatment. One way they do this is by checking for the presence of leukemia stem cells. These cells are the core cells that allow the cancer to grow and persist.
This large study looked at thousands of patients to see if these stem cells affected survival. The results showed that patients with a positive count of these stem cells had a much lower chance of survival. This was true whether the test was done at the start of treatment or after the patient was in remission.
Additionally, patients with these stem cells were more likely to experience complications or have their disease return. Because these results were so consistent, the study suggests that checking for these cells is a useful tool for doctors. It helps them understand the risks and plan better care for their patients.
